TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

CALCIUM GLUCONATE

CALCIUM GLUCONATE
Approved 2017-06-15
5
Indications
--
Phase 3 Trials
8
Years on Market

Details

Status
Prescription
First Approved
2017-06-15
Routes
INTRAVENOUS
Dosage Forms
SOLUTION

CALCIUM GLUCONATE Approval History

Loading approval history...

What CALCIUM GLUCONATE Treats

1 indications

CALCIUM GLUCONATE is approved for 1 conditions since its original approval in 2017. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Hypocalcemia
Source: FDA Label
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

CALCIUM GLUCONATE FDA Label Details

Pro

Indications & Usage

FDA Label (PDF)

Calcium gluconate injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use The safety of calcium gluconate injection for long term use has not been established. Calcium gluconate injection is a form of calcium indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia. Limitations of Use: The safety of calcium gluconate injection for long term use has not been established.

CALCIUM GLUCONATE Patents & Exclusivity

Latest Patent: Jul 2037

Patents (6 active)

US10130646 Expires Jul 25, 2037
Source: FDA Orange Book

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.